Furthermore, survival curve and Cox regression analyses showed that glioma patients with high PVT1 expression or low HAR1A expression had poor survival outcome, aberrantly expressed PVT1 and HAR1A could be the independent prognosis biomarkers for diffuse glioma patients. The gene discussed is PVT1; the disease is glioma.